Nutrigenomics Market Summary
According to Market Research Future analysis, the Nutrigenomics Market Size was estimated at 0.68 USD Billion in 2024. The Nutrigenomics industry is projected to grow from USD 0.799 Billion in 2025 to USD 4.008 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 17.5% during the forecast period 2025 - 2035. North America led the market with over 45% share, generating around USD 0.3 billion in revenue.
Rising demand for personalized nutrition driven by genetic testing adoption, increasing prevalence of lifestyle disorders, and consumer shift toward preventive healthcare accelerates nutrigenomics market growth globally, supported by advancements in sequencing technologies and digital health integration improving accessibility and affordability.
WHO reports over 1 billion people living with obesity in 2022, while CDC notes 41.9% of U.S. adults affected by obesity (2017–2020). IHME estimates non-communicable diseases account for 74% of global deaths, reinforcing demand for preventive, gene-based nutritional interventions worldwide.
Key Market Trends & Highlights
The Nutrigenomics Market is experiencing robust growth driven by personalized nutrition and technological advancements.
- North America leads with 45% share of global nutrigenomics market revenue in 2024 driven by precision nutrition demand
- Europe holds 30% market share valued at USD 0.20 billion in 2024, second largest regional market globally expanding
- Personalized nutrition dominates application segment with 55% share driven by genetic testing adoption and lifestyle disease prevention needs
- Over 1 billion people globally affected by obesity, accelerating nutrigenomics adoption for preventive and personalized dietary solutions worldwide
Market Size & Forecast
| 2024 Market Size | 0.68 (USD Billion) |
| 2035 Market Size | 4.008 (USD Billion) |
| CAGR (2025 - 2035) | 17.5% |
Major Players
Companies such as Nutrigenomix (CA), DNAfit (GB), 23andMe (US), Genomind (US), Nutrigenomics Ltd (GB), Nutrigenomix Inc (CA), Genetic Health (US), Nutrigenomics Technologies (US) are some of the major participants in the global market.